Nov 20, 2024 · Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men that has spread to other parts of the body. Ibrance is used in …

Oct 7, 2024 · Ibrance (palbociclib) is an expensive medicine used to treat breast cancer, but most people do not pay the full price for this drug. Your insurance, the manufacturer of Ibrance, or …

May 6, 2025 · Easy-to-read patient tips for Ibrance covering how it works, benefits, risks, and best practices.

Oct 8, 2025 · Ibrance package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Apr 25, 2025 · Ibrance is also used with the estrogen receptor antagonist fulvestrant in those with disease progression following hormone therapy. Women who have not reached menopause …

May 22, 2024 · Key Points Ibrance (palbociclib) is a kinase inhibitor that is taken by mouth to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) …

Dec 3, 2024 · Learn about the side effects of Ibrance (palbociclib), from common to rare, for consumers and healthcare professionals.

Oct 2, 2025 · Detailed dosage guidelines and administration information for Ibrance (palbociclib). Includes dose adjustments, warnings and precautions.

Apr 25, 2025 · Ibrance (generic name: palbociclib) comes as a capsule or tablet taken by mouth to treat certain types of breast cancer. Ibrance is taken once a day for 21 days, with a 7 day …

Jun 16, 2025 · Key Points Ibrance (generic name: palbociclib) is not a traditional form of chemotherapy (chemo). Ibrance is a "targeted drug therapy" known as a CDK 4/6 inhibitor. …